27 Jul 2023 --- Galderma sales climbed to US$2 billion for the first time in the first half of this fiscal year, up 6.9% year-on-year. The Swiss manufacturer saw its growth driven by its Dermatological Skincare and Therapeutic Dermatology categories, while its range of injectable treatments posted double-digit performance. Despite the uncertain macroeconomic environment, consumer demand for premium products remained resilient, the company maintains.
